trial · primary record
GEN1042
Malignant Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 8 |
| Primary completion | 2027-08 |
| Primary endpoint | Number of Participants with Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT06057038 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:55.321Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06057038
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.